Rallybio Corporation - Common Stock (NQ:RLYB)

17.08 UNCHANGED

Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Rallybio Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >

12 Health Care Stocks Moving In Monday's After-Market Session ↗

July 14, 2025

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

July 09, 2025

Via Benzinga

Top movers in Tuesday's session ↗

July 08, 2025

Let's have a look at what is happening on the US markets one hour before the close of the markets on Tuesday. Below you can find the top gainers and losers in today's session.

Via Chartmill

Most active stocks in Tuesday's session ↗

July 08, 2025

Let's have a look at what is happening on the US markets on Tuesday. Below you can find the most active stocks in today's session.

Via Chartmill

Here's Why Shares in Recursion Pharmaceuticals Surged Today ↗

July 08, 2025

Via The Motley Fool

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

July 08, 2025

Via Benzinga

What's going on in today's session ↗

July 08, 2025

Intrigued by the market activity in the middle of the day on Tuesday? Uncover the key winners and losers of today's session in our insightful analysis.

Via Chartmill

Gapping stocks in Tuesday's session ↗

July 08, 2025

In today's session, there are notable price gaps in the US markets on Tuesday. Take a closer look at the stocks that are gap up and gap down.

Via Chartmill

Why Is Microcap Rallybio Stock Trading Higher On Tuesday? ↗

July 08, 2025

Rallybio sells its stake in preclinical HPP drug REV102 to Recursion in a deal worth up to $25 million, including equity and milestone payments.

Via Benzinga

Rallybio Sells Interest in REV102 Program to Recursion Pharmaceuticals

July 08, 2025

From Rallybio Corporation

Via Business Wire

12 Health Care Stocks Moving In Monday's After-Market Session ↗

June 30, 2025

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

June 13, 2025

Via Benzinga

Rallybio Initiates Dosing in RLYB116 Phase 1 Confirmatory Pharmacokinetic/Pharmacodynamic Study

June 12, 2025

From Rallybio Corporation

Via Business Wire

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

June 04, 2025

Via Benzinga

Rallybio Reports First Quarter 2025 Financial Results and Provides Business Updates

May 08, 2025

From Rallybio Corporation

Via Business Wire

Rallybio to Present at the 2025 Citizens JMP Life Sciences Conference

April 29, 2025

From Rallybio Corporation

Via Business Wire

This General Motors Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday ↗

April 15, 2025

Via Benzinga

Which stocks have an unusual volume on Monday? ↗

April 14, 2025

Unusual volume stocks are being observed in Monday's session.

Via Chartmill

This PTC Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday ↗

April 09, 2025

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

April 08, 2025

Via Benzinga

Rallybio Stock Plunges After Program For Pediatric Bleeding Disorder Disappoints ↗

April 08, 2025

Rallybio ends RLYB212 trial for FNAIT; shifts focus to RLYB116 and preclinical assets with 2025 trial milestones and $6 billion market potential.

Via Benzinga

Rallybio to Discontinue Development of RLYB212 for Prevention of FNAIT

April 08, 2025

From Rallybio Corporation

Via Business Wire

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

March 18, 2025

Via Benzinga

Rallybio Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates

March 13, 2025

From Rallybio Corporation

Via Business Wire

Rallybio to Present at the TD Cowen 45th Annual Health Care Conference

February 25, 2025

From Rallybio Corporation

Via Business Wire

Rallybio Announces Initiation of Dosing in RLYB212 Phase 2 Clinical Trial

February 11, 2025

From Rallybio Corporation

Via Business Wire

Rallybio Highlights 2024 Accomplishments and Anticipated Milestones for 2025

January 10, 2025

From Rallybio Corporation

Via Business Wire

Rallybio Announces Promising RLYB212 and RLYB332 Preclinical Data at the 66th American Society of Hematology Annual Meeting

December 10, 2024

From Rallybio Corporation

Via Business Wire

Rallybio to Initiate RLYB116 Confirmatory Clinical PK/PD Study in Second Quarter 2025

December 02, 2024

From Rallybio Corporation

Via Business Wire

Rallybio Announces Publication of Target-Mediated Drug Disposition Modeling and Simulations Informing the RLYB212 Dosing Regimen in Pregnant Women

November 27, 2024

From Rallybio Corporation

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.